CD44 and Hepatic fibrosis: Hence, it is possible that TSG-6 physically inhibits the catalytic activity of MMP14 and protects CD44 cleavage to CD44ICD from MMP14 to reduce HSC activation and liver fibrosis in mice with ALD.